ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
EHA 2024 Insights: SEQUOIA Trial (Arm D) - Zanubrutinib + Venetoclax in Treatment-Naïve CLL/SLL Patients With del(17p) and/or TP53 Mutation
By
ecancer
FEATURING
Alessandra Tedeschi
By
ecancer
FEATURING
Alessandra Tedeschi
Login to view comments.
Click here to Login
